Positions en cours
| Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 29/04/24 | ARCURE | Achat | 300 E | 5.82 | 2.66 | -54.44% | -163 | 
|
0 |
| 25/04/24 | LARGO | Achat | 300 E | 2.49 | 1.38 | -44.53% | -134 |
|
0 |
| 11/04/24 | LARGO | Achat | 300 E | 2.42 | 1.38 | -42.93% | -129 |
|
4 |
| 27/02/24 | MEMSCAP | Achat | 300 E | 8.66 | 4.60 | -47.04% | -141 |
|
0 |
| 26/02/24 | ABIVAX | Achat | 300 E | 13.10 | 119.20 | 807.90% | 2 424 |
|
0 |
| 26/02/24 | MEMSCAP | Achat | 300 E | 8.52 | 4.60 | -46.32% | -139 |
|
0 |
| 26/02/24 | ARCURE | Achat | 300 E | 4.43 | 2.66 | -40.27% | -121 |
|
0 |
| 26/02/24 | ARCURE | Achat | 300 E | 4.47 | 2.66 | -40.81% | -122 |
|
0 |
| 26/02/24 | ABIVAX | Achat | 300 E | 13.30 | 119.20 | 794.25% | 2 383 |
|
0 |
| 09/01/24 | VALBIOTIS | Achat | 400 E | 4.90 | 0.80 | -83.95% | -336 |
|
0 |
| 09/01/24 | VALBIOTIS | Achat | 400 E | 4.90 | 0.80 | -83.95% | -336 |
|
0 |
| 09/03/23 | MANITOU GROUP | Achat | 300 E | 24.25 | 19.54 | -19.60% | -59 |
|
1 |
| 27/01/23 | MANITOU GROUP | Achat | 300 E | 26.40 | 19.54 | -26.16% | -78 |
|
1 |
| 29/09/22 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.91 | 3.22 | -34.71% | -104 |
|
2 |
| 27/09/22 | INNATE PHARMA | Achat | 300 E | 2.16 | 1.51 | -30.52% | -92 |
|
2 |
| 27/09/22 | INNATE PHARMA | Achat | 300 E | 2.17 | 1.51 | -30.85% | -93 |
|
2 |
| 27/09/22 | INNATE PHARMA | Achat | 300 E | 2.16 | 1.51 | -30.52% | -92 |
|
2 |
| 30/12/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 7.12 | 3.22 | -54.89% | -165 |
|
3 |
| 20/11/20 | OSE IMMUNOTHERAPEUTICS | Achat | 200 E | 7.54 | 3.22 | -57.41% | -115 |
|
4 |
| 08/10/20 | INNATE PHARMA | Achat | 300 E | 3.25 | 1.51 | -53.75% | -161 |
|
6 |
| 15/01/20 | INNATE PHARMA | Achat | 300 E | 6.33 | 1.51 | -76.30% | -229 |
|
6 |
| 15/01/19 | INNATE PHARMA | Achat | 200 E | 7.24 | 1.51 | -79.29% | -159 |
|
7 |
| 15/11/18 | INNATE PHARMA | Achat | 200 E | 8.46 | 1.51 | -82.29% | -165 |
|
10 |
| 06/02/17 | INNATE PHARMA | Achat | 200 E | 10.42 | 1.51 | -85.64% | -171 |
|
20 |
| 14/07/15 | INNATE PHARMA | Achat | 300 E | 14.22 | 1.51 | -89.62% | -269 |
|
14 |
| Enregistrements 1 à 25 sur 25 | |||||||||
Positions soldées
| Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 21/10/25 | ABIVAX | Achat | 300 E | 13.22 | 78.40 | 492.35% | 1 477 |  |
0 |
| 15/08/24 | OSE IMMUNOTHERAPEUTICS | Achat | 2 000 E | 6.91 | 7.08 | 2.26% | 45 | |
0 |
| 11/04/24 | BIO-UV GROUP | Achat | 300 E | 3.14 | 2.21 | -29.79% | -89 | |
0 |
| 11/04/24 | BIO-UV GROUP | Achat | 300 E | 3.09 | 2.21 | -28.65% | -86 | |
0 |
| 28/02/24 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 5.22 | 5.38 | 2.86% | 14 | |
0 |
| 28/02/24 | OSE IMMUNOTHERAPEUTICS | Achat | 2 000 E | 5.16 | 5.44 | 5.22% | 104 | |
0 |
| 28/02/24 | OSE IMMUNOTHERAPEUTICS | Achat | 200 E | 4.12 | 5.56 | 34.72% | 69 | |
10 |
| 26/02/24 | DELFINGEN INDUSTRY | Achat | 300 E | 35.70 | 37.40 | 4.35% | 13 | |
2 |
| 26/02/24 | DELFINGEN INDUSTRY | Achat | 300 E | 38.20 | 37.40 | -2.29% | -7 | |
2 |
| 22/02/24 | LVMH | Achat | 1 000 E | 704.80 | 829.00 | 14.60% | 146 | |
0 |
| 19/02/24 | LVMH | Achat | 1 000 E | 700.20 | 818.00 | 13.94% | 139 | |
0 |
| 19/02/24 | INVENTIVA | Achat | 300 E | 5.03 | 3.19 | -36.74% | -110 | |
1 |
| 19/02/24 | INVENTIVA | Achat | 400 E | 5.58 | 3.19 | -42.99% | -172 | |
1 |
| 13/02/24 | ADOCIA | Achat | 1 000 E | 8.10 | 10.18 | 23.57% | 236 | |
0 |
| 13/02/24 | ADOCIA | Achat | 1 000 E | 11.12 | 10.18 | -9.79% | -98 | |
0 |
| 13/02/24 | ADOCIA | Achat | 1 000 E | 10.92 | 10.18 | -7.98% | -80 | |
0 |
| 02/01/24 | ADOCIA | Achat | 1 500 E | 7.76 | 11.74 | 50.18% | 753 | |
0 |
| 04/12/23 | ADOCIA | Achat | 1 000 E | 7.60 | 8.58 | 11.23% | 112 | |
0 |
| 04/12/23 | MEDIAN TECHNOLOGIES | Achat | 300 E | 1.81 | 3.80 | 109.63% | 329 | |
7 |
| 13/10/23 | ADOCIA | Achat | 1 000 E | 7.60 | 7.69 | 0.76% | 8 | |
0 |
| 12/10/23 | GENSIGHT BIOLOGICS SA | Achat | 300 E | 4.66 | 0.64 | -86.49% | -259 | |
6 |
| 12/10/23 | GENSIGHT BIOLOGICS SA | Achat | 300 E | 3.54 | 0.64 | -82.16% | -246 | |
2 |
| 12/10/23 | MANITOU GROUP | Achat | 1 000 E | 26.25 | 20.50 | -28.09% | -281 | |
1 |
| 21/08/23 | ROCTOOL SA | Achat | 300 E | 4.24 | 3.03 | -28.71% | -86 | |
3 |
| 21/08/23 | ROCTOOL SA | Achat | 300 E | 4.36 | 3.03 | -30.67% | -92 | |
2 |
| 18/08/23 | CASINO GUICHARD-PERRACHON SA | Achat | 2 000 E | 3.01 | 3.19 | 5.57% | 111 | |
0 |
| 18/08/23 | GENSIGHT BIOLOGICS SA | Achat | 300 E | 3.54 | 0.41 | -88.64% | -266 | |
2 |
| 18/08/23 | GENSIGHT BIOLOGICS SA | Achat | 300 E | 3.44 | 0.41 | -88.31% | -265 | |
2 |
| 18/08/23 | GENSIGHT BIOLOGICS SA | Achat | 300 E | 3.41 | 0.41 | -88.09% | -264 | |
2 |
| 30/06/23 | DELFINGEN INDUSTRY
 |
DIV | 0 E | 0.00 | 0.64 | 0.00% | 5 | |
0 |
| 30/06/23 | DELFINGEN INDUSTRY
|
DIV | 0 E | 0.00 | 0.64 | 0.00% | 5 | |
0 |
| 20/06/23 | GENSIGHT BIOLOGICS SA | Achat | 300 E | 4.09 | 1.02 | -75.31% | -226 | |
5 |
| 10/05/23 | ROCTOOL SA | Achat | 300 E | 4.36 | 2.89 | -33.88% | -102 | |
2 |
| 25/01/23 | INVENTIVA | Achat | 300 E | 4.91 | 5.80 | 17.42% | 52 | |
1 |
| 22/12/22 | POXEL | Achat | 300 E | 1.58 | 1.02 | -35.77% | -107 | |
3 |
| 22/12/22 | POXEL | Achat | 300 E | 1.58 | 1.02 | -35.77% | -107 | |
3 |
| 22/12/22 | POXEL | Achat | 300 E | 1.56 | 1.02 | -34.95% | -105 | |
2 |
| 22/12/22 | POXEL | Achat | 300 E | 1.47 | 1.02 | -30.78% | -92 | |
2 |
| 27/09/22 | THERADIAG | Achat | 300 E | 1.41 | 2.30 | 62.86% | 189 | |
6 |
| 27/09/22 | THERADIAG | Achat | 300 E | 2.15 | 2.30 | 6.56% | 20 | |
8 |
| 27/09/22 | THERADIAG | Achat | 300 E | 1.40 | 2.30 | 63.76% | 191 | |
3 |
| 26/09/22 | ESKER | Achat | 300 E | 118.80 | 121.20 | 1.82% | 5 | |
3 |
| 26/09/22 | MEDIAN TECHNOLOGIES | Achat | 300 E | 1.96 | 8.16 | 315.81% | 947 | |
6 |
| 26/09/22 | EUROFINS SCIENTIFIC SE
|
Achat | 300 E | 47.80 | 60.64 | 26.64% | 80 | |
7 |
| 26/09/22 | EUROFINS SCIENTIFIC SE
|
Achat | 300 E | 68.34 | 60.64 | -11.64% | -35 | |
6 |
| 26/09/22 | EUROFINS SCIENTIFIC SE
|
Achat | 300 E | 69.82 | 60.64 | -13.52% | -41 | |
5 |
| 26/09/22 | ESKER | Achat | 300 E | 80.70 | 121.00 | 49.69% | 149 | |
11 |
| 26/09/22 | LECTRA | Achat | 300 E | 40.45 | 28.90 | -28.90% | -87 | |
3 |
| 19/11/21 | ACTIA GROUP | Achat | 300 E | 2.51 | 3.36 | 33.63% | 101 | |
4 |
| 19/11/21 | ACTIA GROUP | Achat | 300 E | 2.51 | 3.36 | 33.63% | 101 | |
3 |
| Enregistrements 1 à 50 sur 643 | |||||||||